09:40 AM EST - Knight Therapeutics Inc. : Will release its fourth-quarter and year-end 2023 financial results on Thursday, March 21, prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Knight Therapeutics Inc.
shares T.GUD are trading unchanged at $5.28.
